Vous êtes ici : Accueil / Valorisation / Publications / 2019

Infos pratiques

Organigramme
Contacts
  • Directeur :

        Pr Eric DELAPORTE

  • Directeur Adjoint :

        Bernard TAVERNE

Accès à la Délégation Régionale IRD-Occitanie (Montpellier)

2019

Avila E., Tagg N., Willie J., Mbohli D., Farfan M. A., Vargas J. M., Bonat W. H., Dupain J., Epanda M. A., Luyten I., Tedonzong L., Peeters Martine, Fa J. E.,
Interpreting long-term trends in bushmeat harvest in southeast Cameroon,
Acta Oecologica : International Journal of Ecology, p. 57‑65, 2019.

Ba A., Ndiaye F. K., Djeng Y. J., Cames C., Diack A., et N’diaye O.,
Impact of Highly Active Antiretroviral Therapy on Chronic Hepatitis B Serological Markers among Senegalese HIV Co-infected Children,
Int J MCH AIDS, vol. 8, no 2, p. 131‑137, 2019. doi: 10.21106/ijma.321.

Dahourou D. L., Masson D., Aka-Dago-Akribi H., Gauthier-Lafaye C., Cacou C., Raynaud J.-P., Moh C., Bouah B., Sturm G., Oga M., Msellati P., Leroy V., et Le Groupe Atelier Annonce Adolescents Afrique,
HIV Disclosure to the Child/Adolescent in Central and West Francophone Africa,
Bull Soc Pathol Exot, vol. 112, no 1, p. 14‑21, 2019. doi: 10.3166/bspe-2019-0063.

Vieillard V., Combadière B., Tubiana R., Launay O., Pialoux G., Cotte L., Girard P.-M., Simon A., Dudoit Y., Reynes J., Rockstroh J., Garcia F., Gatell J., Devidas A., Yazdanpanah Y., Weiss L., Fätkenheuer G., Autran B., Joyeux D., Gharakhanian S., Debré P., et Katlama C.,
HIV therapeutic vaccine enhances non-exhausted CD4+ T cells in a randomised phase 2 trial,
NPJ Vaccines, vol. 4, p. 25, 2019. doi: 10.1038/s41541-019-0117-5.

Vinken L., Fransen K., Cuypers L., Alexiev I., Balotta C., Debaisieux L., Seguin-Devaux C., García Ribas S., Gomes P., Incardona F., Kaiser R., Ruelle J., Sayan M., Paraschiv S., Paredes R., Peeters M., Sönnerborg A., Vancutsem E., Vandamme A.-M., Van den Wijngaert S., Van Ranst M., Verhofstede C., Stadler T., Lemey P., et Van Laethem K.,
Earlier Initiation of Antiretroviral Treatment Coincides With an Initial Control of the HIV-1 Sub-Subtype F1 Outbreak Among Men-Having-Sex-With-Men in Flanders, Belgium,
Front Microbiol, vol. 10, p. 613, 2019. doi: 10.3389/fmicb.2019.00613.

Younas M., Psomas C., Reynes C., Cezar R., Kundura L., Portales P., Merle C., Atoui N., Fernandez C., Le Moing V., Barbuat C., Moranne O., Sotto A., Sabatier R., Fabbro P., Vincent T., Dunyach-Remy C., Winter A., Reynes J., Lavigne J.-P., et Corbeau P.,
Microbial Translocation Is Linked to a Specific Immune Activation Profile in HIV-1-Infected Adults With Suppressed Viremia,
Front Immunol, vol. 10, p. 2185, 2019. doi: 10.3389/fimmu.2019.02185.

Lipworth S., Jajou R., de Neeling A., Bradley P., van der Hoek W., Maphalala G., Bonnet M., Sanchez-Padilla E., Diel R., Niemann S., Iqbal Z., Smith G., Peto T., Crook D., Walker T., et van Soolingen D.,
SNP-IT Tool for Identifying Subspecies and Associated Lineages of Mycobacterium tuberculosis Complex,
Emerging Infect. Dis., vol. 25, no 3, p. 482‑488, 2019. doi: 10.3201/eid2503.180894.

NAMSAL ANRS 12313 Study Group, Kouanfack C., Mpoudi-Etame M., Omgba Bassega P., Eymard-Duvernay S., Leroy S., Boyer S., Peeters M., Calmy A., et Delaporte E.,
Dolutegravir-Based or Low-Dose Efavirenz-Based Regimen for the Treatment of HIV-1,
N. Engl. J. Med., vol. 381, no 9, p. 816‑826, 29 2019. doi: 10.1056/NEJMoa1904340.

Chesnais C. B. et Boussinesq M.,
Onchocerciasis-associated epilepsy – Authors’ reply,
The Lancet Infectious Diseases, vol. 19, no 1, p. 22, janv. 2019. doi: 10.1016/S1473-3099(18)30743-6.

Le Marcis F.,
Life in a Space of Necropolitics: Toward an Economy of Value in Prisons,
Ethnos, vol. 84, no 1, p. 74‑95, janv. 2019. doi: 10.1080/00141844.2018.1428207.

Liégeois F., Eymard-Duvernay S., Boyer S., Maradan G., Kouanfack C., Domyeum J., Boyer V., Mpoudi-Ngolé E., Spire B., Delaporte E., Vidal L., Kuaban C., Laurent C., et the EVOLCAM study group,
Heterogeneity of virological suppression in the national antiretroviral programme of Cameroon (ANRS 12288 EVOLCAM),
HIV Medicine, vol. 20, no 1, p. 38‑46, janv. 2019. doi: 10.1111/hiv.12681.

Ortiz-Baez A. S., Cunha M. dos P., Vedovello D., Colombo T. E., Nogueira M. L., Villabona-Arenas C. J., et Zanotto P. M. de A.,
Origin, tempo, and mode of the spread of DENV-4 Genotype IIB across the state of São Paulo, Brazil during the 2012-2013 outbreak,
Memórias do Instituto Oswaldo Cruz, vol. 114, no 0, janv. 2019. doi: 10.1590/0074-02760180251.

Hejoaka F., Varloteaux M., Desclaux-Sall C., Ndiaye S. M., Diop K., Diack A., Niasse F., et Cames C.,
Improving the informed consent process among HIV-infected undisclosed minors participating in a biomedical research: insights from the multicentre nutritional SNACS study in Senegal,
Trop. Med. Int. Health, janv. 2019. doi: 10.1111/tmi.13202.

Nikiema A., Bonnet E., Tougma A., et Le Marcis F.,
Closer is not better. Distance and proximity in the use of health care by women living with HIV and AIDS in Ouagadougou (Burkina Faso),
Cybergeo, janv. 2019. doi: 10.4000/cybergeo.31502.

Ayouba A., Ahuka-Mundeke S., Butel C., Mbala Kingebeni P., Loul S., Tagg N., Arenas C.-J. V., Lacroix A., Ndimbo-Kumugo S.-P., Keita A. K., Toure A., Couacy-Hymann E., Calvignac-Spencer S., Leendertz F. H., Formenty P., Delaporte E., Muyembe-Tamfum J.-J., Ngole E. M., et Peeters M.,
Extensive serological survey of multiple African non-human primate species reveals low prevalence of IgG antibodies to four Ebola virus species,
J. Infect. Dis., janv. 2019. doi: 10.1093/infdis/jiz006.

Baudel H., De Nys H., Mpoudi Ngole E., Peeters M., et Desclaux A.,
Understanding Ebola virus and other zoonotic transmission risks through human-bat contacts: Exploratory study on knowledge, attitudes and practices in Southern Cameroon,
Zoonoses Public Health, janv. 2019. doi: 10.1111/zph.12563.

Gatti G., Chocron S., Obadia J.-F., Duval X., Iung B., Alla F., Chirouze C., Lecompte T., Hoen B., Delahaye F., Tattevin P., Le Moing V., Perrotti A., et Association for the Study and Prevention of Infective Endocarditis Study Group – Association pour l’Étude et la Prévention de l’Endocadite Infectieuse (AEPEI),
Using surgical risk scores in nonsurgically treated infective endocarditis patients,
Hellenic J Cardiol, janv. 2019. doi: 10.1016/j.hjc.2019.01.008.

Borand L., de Lauzanne A., Nguyen N. L., Cheng S., Pham T. H., Eyangoh S., Ouedraogo A.-S., Ung V., Msellati P., Tejiokem M., Nacro B., Inghammar M., Dim B., Delacourt C., Godreuil S., Blanche S., Marcy O., et Pediatric Asian African Network for Tuberculosis and HIV Research (PAANTHER)
Study Group,Isolation of Nontuberculous Mycobacteria in Southeast Asian and African Human Immunodeficiency Virus-infected Children With Suspected Tuberculosis,
Clin. Infect. Dis., janv. 2019. doi: 10.1093/cid/ciy897.

Jacquet J.-M., Donnadieu-Rigole H., Peries M., Makinson A., Nagot N., Reynes J., Peyriere H., et MesConsos study group name,
Implementing screening, brief intervention and referral to treatment in a French cohort of people living with HIV: a pilot study,
HIV Med., janv. 2019. doi: 10.1111/hiv.12709.

Hemelaar J., Elangovan R., Yun J., Dickson-Tetteh L., Fleminger I., Kirtley S., Williams B., Gouws-Williams E., Ghys P. D., Abimiku A. G., Agwale S., Archibald C., Avidor B., Barbás M. G., Barre-Sinoussi F., Barugahare B., Belabbes E. H., Bertagnolio S., Birx D., Bobkov A. F., Brandful J., Bredell H., Brennan C. A., Brooks J., Bruckova M., Buonaguro L., Buonaguro F., Buttò S., Buve A., Campbell M., Carr J., Carrera A., Carrillo M. G., Celum C., Chaplin B., Charles M., Chatzidimitriou D., Chen Z., Chijiwa K., Cooper D., Cunningham P., Dagnra A., de Gascun C. F., Del Amo J., Delgado E., Dietrich U., Dwyer D., Ellenberger D., Ensoli B., Essex M., Gao F., Fleury H., Fonjungo P. N., Foulongne V., Gadkari D. A., García F., Garsia R., Gershy-Damet G. M., Glynn J. R., Goodall R., Grossman Z., Lindenmeyer-Guimarães M., Hahn B., Hamers R. L., Hamouda O., Handema R., He X., Herbeck J., Ho D. D., Holguin A., Hosseinipour M., Hunt G., Ito M., Bel Hadj Kacem M. A., Kahle E., Kaleebu P. K., Kalish M., Kamarulzaman A., Kang C., Kanki P., Karamov E., Karasi J.-C., Kayitenkore K., Kelleher T., Kitayaporn D., Kostrikis L. G., Kucherer C., Lara C., Leitner T., Liitsola K., Lingappa J., Linka M., Lorenzana de Rivera I., Lukashov V., Maayan S., Mayr L., McCutchan F., Meda N., Menu E., Mhalu F., Mloka D., Mokili J. L., Montes B., Mor O., Morgado M., Mosha F., Moussi A., Mullins J., Najera R., Nasr M., Ndembi N., Neilson J. R., Nerurkar V. R., Neuhann F., Nolte C., Novitsky V., Nyambi P., Ofner M., Paladin F. J., Papa A., Pape J., Parkin N., Parry C., Peeters M., Pelletier A., Pérez-Álvarez L., Pillay D., Pinto A., Quang T. D., Rademeyer C., Raikanikoda F., Rayfield M. A., Reynes J.-M., Rinke de Wit T., Robbins K. E., Rolland M., Rousseau C., Salazar-Gonzales J., Salem H., Salminen M., Salomon H., Sandstrom P., Santiago M. L., Sarr A. D., Schroeder B., Segondy M., Selhorst P., Sempala S., Servais J., Shaik A., Shao Y., Slim A., Soares M. A., Songok E., Stewart D., Stokes J., Subbarao S., Sutthent R., Takehisa J., Tanuri A., Tee K. K., Thapa K., Thomson M., Tran T., Urassa W., Ushijima H., van de Perre P., van der Groen G., van Laethem K., van Oosterhout J., van Sighem A., van Wijngaerden E., Vandamme A.-M., Vercauteren J., Vidal N., Wallace L., Williamson C., Wolday D., Xu J., Yang C., Zhang L., et Zhang R.,
Global and regional molecular epidemiology of HIV-1, 1990–2015: a systematic review, global survey, and trend analysis,
The Lancet Infectious Diseases, vol. 19, no 2, p. 143‑155, févr. 2019. doi: 10.1016/S1473-3099(18)30647-9.

Oliosi J. G. N., Reis-Santos B., Locatelli R. L., Sales C. M. M., da Silva Filho W. G., da Silva K. C., Sanchez M. N., de Andrade K. V. F., de Araújo G. S., Shete P. B., Pereira S. M., Riley L. W., Lienhardt C., et Maciel E. L. N.,
Effect of the Bolsa Familia Programme on the outcome of tuberculosis treatment: a prospective cohort study,
The Lancet Global Health, vol. 7, no 2, p. e219‑e226, févr. 2019. doi: 10.1016/S2214-109X(18)30478-9.

Psomas C., Tuaillon E., Marin G., Reynes J., et Corbeau P.,
Increased Neutrophil Surface PD-L1 Expression in Tobacco Smokers: Consequences for Anti–PD-1 Treatment,
JAIDS Journal of Acquired Immune Deficiency Syndromes, vol. 80, no 2, p. e48‑e49, févr. 2019. doi: 10.1097/QAI.0000000000001897.

Ngo-Giang-Huong N., Huynh T. H. K., Dagnra A. Y., Toni T., Maiga A. I., Kania D., Eymard-Duvernay S., Peeters M., Soulie C., Peytavin G., Rekacewicz C., Chaix M.-L., Aghokeng A. F., ANRS 12333 Study Group, Aghokeng A. F., Ayouba A., Brun-Vézinet F., Chaix M.-L., Calvez V., Dagnra A., Descamps D., Dramane K., Fournier I., Maiga A., de Monteynard L.-A., Nouhin J., Kane C. T., Lien T. X., Ngo-Giang-Huong N., Peeters M., Plantier J.-C., Njouom R., Tuaillon E., Rekacewicz C., d’Aquin T. T., Poda A., Zougrana J., Ouedraogo S., Ouedraogo M., Djeuda A. D., Kouanfack C., Mandeng N., Mpoudi-Ngole E., Messou E., Jacques D. J., Nguessan J. F., Dolo O., Diarra Z., Cisse M., Patassi A., Salou M., Ali-Edjé K., Bowonwatanuwong C., Thongpaen S., Klinbuayaem V., Laomanit L., Luong Q. A., et Tran T.,
Prevalence of pretreatment HIV drug resistance in West African and Southeast Asian countries,
Journal of Antimicrobial Chemotherapy, vol. 74, no 2, p. 462‑467, févr. 2019. doi: 10.1093/jac/dky443.

Di Paola N., Mesquita F. S., Oliveira D. B. L. de, Villabona-Arenas C. J., Zaki Pour S., de Sousa-Capra C., Lopes G. P., Santana R. A. F., Pinho J. R. R., Balarini K., Pereira da Fonseca C. R. T., et Zanotto P. M. de A.,
An Outbreak of Human Parvovirus B19 Hidden by Dengue Fever,
Clinical Infectious Diseases, vol. 68, no 5, p. 810‑817, févr. 2019. doi: 10.1093/cid/ciy630.

Bibollet-Ruche F., Russell R. M., Liu W., Stewart-Jones G. B. E., Sherrill-Mix S., Li Y., Learn G. H., Smith A. G., Gondim M. V. P., Plenderleith L. J., Decker J. M., Easlick J. L., Wetzel K. S., Collman R. G., Ding S., Finzi A., Ayouba A., Peeters M., Leendertz F. H., van Schijndel J., Goedmakers A., Ton E., Boesch C., Kuehl H., Arandjelovic M., Dieguez P., Murai M., Colin C., Koops K., Speede S., Gonder M. K., Muller M. N., Sanz C. M., Morgan D. B., Atencia R., Cox D., Piel A. K., Stewart F. A., Ndjango J.-B. N., Mjungu D., Lonsdorf E. V., Pusey A. E., Kwong P. D., Sharp P. M., Shaw G. M., et Hahn B. H.,
CD4 receptor diversity in chimpanzees protects against SIV infection,
Proc. Natl. Acad. Sci. U.S.A., vol. 116, no 8, p. 3229‑3238, févr. 2019. doi: 10.1073/pnas.1821197116.

Reis-Santos B., Shete P., Bertolde A., Sales C. M., Sanchez M. N., Arakaki-Sanchez D., Andrade K. B., Gomes M. G. M., Boccia D., Lienhardt C., et Maciel E. L.,
Tuberculosis in Brazil and cash transfer programs: A longitudinal database study of the effect of cash transfer on cure rates,
PLOS ONE, vol. 14, no 2, p. e0212617, févr. 2019. doi: 10.1371/journal.pone.0212617.

Lê M. P., Valantin M.-A., Assoumou L., Soulie C., Le Mestre S., Weiss L., Yazdanpanah Y., Molina J.-M., Bouchaud O., Raffi F., Reynes J., Calvez V., Marcelin A.-G., Costagliola D., Katlama C., Peytavin G., et ANRS-163 ETRAL study group,
Lack of a Clinically Significant Pharmacokinetic Interaction between Etravirine and Raltegravir Using an Original Approach Based on Drug Metabolism, Protein Binding, and Penetration in Seminal Fluid: A Pharmacokinetic Substudy of the ANRS-163 ETRAL Study,
Pharmacotherapy, févr. 2019. doi: 10.1002/phar.2242.

Diallo M. S. K., Rabilloud M., Ayouba A., Touré A., Thaurignac G., Keita A. K., Butel C., Kpamou C., Barry T. A., Sall M. D., Camara I., Leroy S., Msellati P., Ecochard R., Peeters M., Sow M. S., Delaporte E., Etard J.-F., et Contactebogui Study Group,
Prevalence of infection among asymptomatic and paucisymptomatic contact persons exposed to Ebola virus in Guinea: a retrospective, cross-sectional observational study,
Lancet Infect Dis, vol. 19, no 3, p. 308‑316, mars 2019. doi: 10.1016/S1473-3099(18)30649-2.

Dion J., Malphettes M., Bénéjat L., Mégraud F., Wargnier A., Boutboul D., Galicier L., Le Moing V., Giraud P., Jaccard A., Nove-Josserand R., Fieschi C., Oksenhendler E., Gérard L., et DEFI study group,
Campylobacter infection in adult patients with primary antibody deficiency,
J Allergy Clin Immunol Pract, vol. 7, no 3, p. 1038-1041.e4, mars 2019. doi: 10.1016/j.jaip.2018.06.014.

Cuzin L., Pugliese P., Katlama C., Bani-Sadr F., Ferry T., Rey D., Lourenco J., Bregigeon S., Allavena C., Reynes J., Cabié A., Dat’AIDS Study Group, Drobacheff-Thiébaut C., Foltzer A., Bouiller K., Hustache-Mathieu L., Chirouze C., Lepiller Q., Bozon F., Babre O., Muret P., Laurichesse H., Lesens O., Vidal M., Mrozek N., Aumeran C., Baud O., Corbin V., Letertre P., Casanova S., Jacomet C., Hoen B., Lamaury I., Fabre I., Curlier E., Ouissa R., Schepers K., Herrmann-Storck C., Dournon N., Merrien D., Perré P., Guimard T., Bollangier O., Leautez S., Morrier M., Ader F., Biron F., Boibieux A., Cotte L., Ferry T., Miailhes P., Perpoint T., Roux S., Degroodt S., Brochier C., Valour F., Chidiac C., Dhiver C., Mokhtari M. S., Ménard A., Dupont H. T., Toméi C., Meddeb L., Belkhir A. Y., Ravaux I., Brégigeon S., Zaegel-Faucher O., Obry-Roguet V., Orticoni M., Soavi M. J., Luquet-Besson I., Ressiot E., Carta-Padovani M., Ducassou M. J., Bertone H., Galie S., Galinier A., Monclar M., Ritleng A. S., Ivanova A., Blanco-Betancourt C., Lions C., Poizot-Martin I., Abel S., Césaire R., Cuzin L., Santos G. D., Fagour L., Illiaquer M., Najioullah F., Nguyen D., Ouka M., Pierre-François S., Pasquier J., Pircher M., Rozé B., Cabié A., Atoui N., Moing V. L., Makinson A., Meftah N., de Boever C. M., Montes B., Ferrer A. M., Reynes J., André M., Boyer L., Bouillon M. P., Delestan M., May T., Allavena C., Bernaud C., Billaud E., Biron C., Bonnet B., Bouchez S., Boutoille D., Brunet-Cartier C., Hall N., Jovelin T., Morineau P., Reliquet V., Hue H., Sécher S., Cavellec M., Soria A., Ferré V., André-Garnier E., Rodallec A., Guen L. L., Lefebvre M., Grossi O., Point P., Aubry O., Khatchatourian L., Raffi F., Pugliese P., Breaud S., Ceppi C., Courjon J., Cua E., Cottalorda J., Dellamonica P., Demonchy E., Monte A. D., Durant J., Etienne C., Ferrando S., Fuzibet J. G., Garraffo R., Joulie A., Risso K., Mondain V., Naqvi A., Oran N., Perbost I., Pillet S., Prouvost-Keller B., Pradier C., Wehrlen-Pugliese S., Rio V., Rosenthal E., Sausse S., Zouzou G., Hocqueloux L., Cheret A., Goujard C., Quertainmont Y., Teicher E., Lerolle N., Vittecoq D., Deradji O., Fourreau F., Pallier C., Barrail-Tran A., Landman R., Joly V., Rioux C., Lariven S., Gervais A., Lescure F. X., Matheron S., Louni F., Godard C., Julia Z., Chansombat M., Rahli D., Mackoumbou-Nkouka C., Charpentier C., Descamps D., Peytavin G., Yazdanpanah Y., Consigny P. H., Cessot G., Bossi P., Goesch J., Gilquin J., Benabdelmoumen G., Lanternier F., Charlier C., Amazzough K., Henry B., Pilmis B., Rouzaud C., Morgand M., Touam F., Louisin C., Duvivier C., Lortholary O., Guery R., Danion F., Lourenco J., Parize P., Etienne N., Launay M., Rouzioux C., Avettand Fenoel V., Valantin M. A., Flandre P., Caby F., Tubiana R., Agher R., Seang S., Schneider L., Palich R., Blanc C., Katlama C., Berger J. L., N’Guyen Y., Lambert D., Lebrun D., Kmiec I., Hentzien M., Brodard V., Bani-Sadr F., Botelho-Nevers E., Gagneux-Brunon A., Frésard A., Lucht F., Fischer P., Partisani M., Cheneau C., Priester M., Batard M. L., Bernard-Henry C., de Mautort E., Rey D., Alvarez M., Biezunski N., Debard A., Delpierre C., Lansalot P., Lelièvre L., Martin-Blondel G., Metsu D., Piffaut M., Porte L., Saune K., Delobel P., Ajana F., Alcaraz I., Baclet V., Boucher A., Choisy P., Huleux T., Lafon-Desmurs B., Melliez H., Meybeck A., Pasquet A., Pradier M., Robineau O., Viget N., et Valette M.,
Integrase strand transfer inhibitors and neuropsychiatric adverse events in a large prospective cohort,
Journal of Antimicrobial Chemotherapy, vol. 74, no 3, p. 754‑760, mars 2019. doi: 10.1093/jac/dky497.

Coulaud P.-J., Préau M., Maradan G., Mora M., Traoré F., Oga M., Thio E., Ekon L., Dembele Keita B., Anoma C., Ter Tiero Dah E., Mensah E., Bernier A., Couderc C., Laurent C., Spire B., et CohMSM Study Group,
Taking empowerment into account: the response of community-based organisations to the HIV care needs of men who have sex with men in West Africa (CohMSM ANRS 12324 - Expertise France),
AIDS Care, p. 1‑9, mars 2019. doi: 10.1080/09540121.2019.1587358.

Nana-Djeunga H. C., Fossuo-Thotchum F., Pion S. D., Chesnais C. B., Kubofcik J., Mackenzie C. D., Klion A. D., Boussinesq M., Nutman T. B., et Kamgno J.,
Loa loa microfilariae in skin snips: consequences for onchocerciasis monitoring and evaluation in L. loa endemic areas,
Clin. Infect. Dis., mars 2019. doi: 10.1093/cid/ciz172.

Boullé C., Njamnshi A. K., Dema F., Mengnjo M. K., Siewe Fodjo J. N., Bissek A.-C. Z.-K., Suykerbuyk P., Lenou-Nanga C. G., Nana-Djeunga H. C., Kamgno J., Chesnais C. B., Boussinesq M., et Colebunders R.,
Impact of 19 years of mass drug administration with ivermectin on epilepsy burden in a hyperendemic onchocerciasis area in Cameroon,
Parasit Vectors, vol. 12, no 1, p. 114, mars 2019. doi: 10.1186/s13071-019-3345-7.

Phillips P. P. J., Mitnick C. D., Neaton J. D., Nahid P., Lienhardt C., et Nunn A. J.,
Keeping phase III tuberculosis trials relevant: Adapting to a rapidly changing landscape,
PLOS Medicine, vol. 16, no 3, p. e1002767, mars 2019. doi: 10.1371/journal.pmed.1002767.

Siméon S., Le Moing V., Tubiana S., Duval X., Fournier D., Lavigne J.-P., Erpelding M.-L., Gustave C.-A., Desage S., Chirouze C., Vandenesch F., Tattevin P., Chirouze C., Curlier E., Descottes-Genon C., Hoen B., Patry I., Vettoretti L., Chavanet P., Eicher J.-C., Gohier-Treuvelot S., Greusard M.-C., Neuwirth C., Péchinot A., Piroth L., Célard M., Cornu C., Delahaye F., Hadid M., Rausch P., Coma A., Galtier F., Géraud P., Jean-Pierre H., Le Moing V., Sportouch C., Reynes J., Aissa N., Doco-Lecompte T., Goehringer F., Keil N., Letranchant L., Malela H., May T., Selton-Suty C., Bedos N., Lavigne J.-P., Lechiche C., Sotto A., Duval X., Habensus E. I., Iung B., Leport C., Longuet P., Ruimy R., Bellissant E., Donnio P.-Y., Le Gac F., Michelet C., Revest M., Tattevin P., Thebault E., Alla F., Braquet P., Erpelding M.-L., Minary L., Tubiana S., Bès M., Etienne J., Lelekov-Boissard T., Tristan A., Vandenesch F., Van Belkum A., Rivadeneira F., Vanwamel W., Barbas S., Delonca C., Sussmuth V., et Verchère A.,
Time to blood culture positivity: An independent predictor of infective endocarditis and mortality in patients with Staphylococcus aureus bacteraemia,
Clinical Microbiology and Infection, vol. 25, no 4, p. 481‑488, avr. 2019. doi: 10.1016/j.cmi.2018.07.015.

Pion S. D., Tchatchueng-Mbougua J. B., Chesnais C. B., Kamgno J., Gardon J., Chippaux J.-P., Ranque S., Ernould J.-C., Garcia A., et Boussinesq M.,
Effect of a Single Standard Dose (150–200 μg/kg) of Ivermectin on Loa loaMicrofilaremia: Systematic Review and Meta-analysis,
Open Forum Infectious Diseases, vol. 6, no 4, avr. 2019. doi: 10.1093/ofid/ofz019.

Gupta-Wright A., Corbett E. L., Wilson D., van Oosterhout J. J., Dheda K., Huerga H., Peter J., Bonnet M., Alufandika-Moyo M., Grint D., Lawn S. D., et Fielding K.,
Risk score for predicting mortality including urine lipoarabinomannan detection in hospital inpatients with HIV-associated tuberculosis in sub-Saharan Africa: Derivation and external validation cohort study,
PLOS Medicine, vol. 16, no 4, p. e1002776, avr. 2019. doi: 10.1371/journal.pmed.1002776.

Mbala-Kingebeni P., Aziza A., Di Paola N., Wiley M. R., Makiala-Mandanda S., Caviness K., Pratt C. B., Ladner J. T., Kugelman J. R., Prieto K., Chitty J. A., Larson P. A., Beitzel B., Ayouba A., Vidal N., Karhemere S., Diop M., Diagne M. M., Faye M., Faye O., Aruna A., Nsio J., Mulangu F., Mukadi D., Mukadi P., Kombe J., Mulumba A., Villabona-Arenas C.-J., Pukuta E., Gonzalez J., Bartlett M. L., Sozhamannan S., Gross S. M., Schroth G. P., Tim R., Zhao J. J., Kuhn J. H., Diallo B., Yao M., Fall I. S., Ndjoloko B., Mossoko M., Lacroix A., Delaporte E., Sanchez-Lockhart M., Sall A. A., Muyembe-Tamfum J.-J., Peeters M., Palacios G., et Ahuka-Mundeke S.,
Medical countermeasures during the 2018 Ebola virus disease outbreak in the North Kivu and Ituri Provinces of the Democratic Republic of the Congo: a rapid genomic assessment,
Lancet Infect Dis, avr. 2019. doi: 10.1016/S1473-3099(19)30118-5.

Turner H. C., Walker M., Pion S. D. S., McFarland D. A., Bundy D. A. P., et Basáñez M.-G.,
Economic evaluations of onchocerciasis interventions: a systematic review and research needs,
Trop. Med. Int. Health, avr. 2019. doi: 10.1111/tmi.13241.

Giles-Vernick T., Kutalek R., Napier D., Kaawa-Mafigiri D., Dückers M., Paget J., Ahmed S. M., Cheah P. Y., Desclaux A., De Vries D., Hardon A., MacGregor H., Pell C., Rashid S. F., Rodyna R., Schultsz C., Sow K., et Wilkinson A.,
A new social sciences network for infectious threats,
The Lancet Infectious Diseases, vol. 19, no 5, p. 461‑463, mai 2019. doi: 10.1016/S1473-3099(19)30159-8.

Pistone T., Ouattara E., Gabillard D., Lele N., Duvignaud A., Cordel H., Malvy D., Bouchaud O., Abgrall S., Bentata M., Fantin B., Goujard C., Matheron S., Launay O., Le Moing V., Lortholary O., Consigny P.-H., Saada M., Katlama C., Simon A., Arvieux C., Campa P., Girard P.-M., Khuong M.-A., Molina J.-M., Lascoux-Combe C., Rey D., Rondeau M., Pialoux G., Couzigou C., Vittecoq D., Patey O., Morlat P., Duong M., et Chavanet P.,
Travel-related health events and their risk factors in HIV-infected sub-Saharan migrants living in France and visiting their native country: The ANRS VIHVO cohort study,
Travel Medicine and Infectious Disease, vol. 29, p. 40‑47, mai 2019. doi: 10.1016/j.tmaid.2019.03.010.

Rzepecki V., Reynes J., Le Moing V., Braquet P., Faucherre V., Lohan L., Morquin D., et Makinson A.,
Severe HIV-associated aphthous stomatitis treated with etanercept,
Médecine et Maladies Infectieuses, vol. 49, no 3, p. 219‑220, mai 2019. doi: 10.1016/j.medmal.2018.11.005.

Kounta C. H., Sagaon-Teyssier L., Coulaud P.-J., Mora M., Maradan G., Bourrelly M., Keita A. A., Yoro S.-A. B., Anoma C., Coulibaly C., Dah E. T. T., Agbomadji S., Mensah E., Bernier A., Couderc C., Dembélé Keita B., Laurent C., Spire B., et the CohMSM Study Group,
Male clients of male sex workers in West Africa: A neglected high-risk population,
PLOS ONE, vol. 14, no 5, p. e0212245, mai 2019. doi: 10.1371/journal.pone.0212245.

Marcis F. L., Enria L., Abramowitz S., Saez A.-M., et Faye S. L. B.,
Three Acts of Resistance during the 2014–16 West Africa Ebola Epidemic,
Journal of Humanitarian Affairs, vol. 1, no 2, p. 23‑31, mai 2019. doi: 10.7227/JHA.014.

Saxena A., Horby P., Amuasi J., Aagaard N., Köhler J., Gooshki E. S., Denis E., Reis A. A., ALERRT-WHO Workshop, et Ravinetto R.,
Ethics preparedness: facilitating ethics review during outbreaks - recommendations from an expert panel,
BMC Med Ethics, vol. 20, no 1, p. 29, mai 2019. doi: 10.1186/s12910-019-0366-x.

Kaboré N. F., Poda A., Zoungrana J., Da O., Ciaffi L., Semdé A., Yaméogo I., Sawadogo A. B., Delaporte E., Meda N., Limou S., et Cournil A.,
Chronic kidney disease and HIV in the era of antiretroviral treatment: findings from a 10-year cohort study in a west African setting,
BMC Nephrol, vol. 20, no 1, p. 155, mai 2019. doi: 10.1186/s12882-019-1335-9.

Kouanfack C., Unal G., Schaeffer L., Kfutwah A., Aghokeng A., Mougnutou R., Tchemgui-Noumsi N., Alessandri-Gradt E., Delaporte E., Simon F., Vray M., et Plantier J.-C.,
Comparative immuno-virological and clinical responses to antiretroviral therapy between HIV-1 group O- and HIV-1 group M-infected patients (ANRS 12168 DynaMO study),
Clinical Infectious Diseases, mai 2019. doi: 10.1093/cid/ciz371.

Guégan J.-F., de Thoisy B., Ayouba A., et Cappelle J.,
Tropical forests, changes in land uses and emerging infectious hazards,
Sante Publique, vol. S1, no HS, p. 91‑106, mai 2019. doi: 10.3917/spub.190.0091.

Ibrahim Y. L., Masouyé I., Tschanz E., Atangana P., Etard J.-F., Serafini M., Mueller Y. K., et Toutous Trellu L.,
Diagnostic Value of Histological Analysis of Punch Biopsies in Suspected Cutaneous Buruli Ulcer: A Study on 32 Cases of Confirmed Buruli Ulcer in Cameroon,
Dermatopathology (Basel), vol. 6, no 2, p. 28‑36, juin 2019. doi: 10.1159/000498969.

Mbala-Kingebeni P., Pratt C. B., Wiley M. R., Diagne M. M., Makiala-Mandanda S., Aziza A., Di Paola N., Chitty J. A., Diop M., Ayouba A., Vidal N., Faye O., Faye O., Karhemere S., Aruna A., Nsio J., Mulangu F., Mukadi D., Mukadi P., Kombe J., Mulumba A., Duraffour S., Likofata J., Pukuta E., Caviness K., Bartlett M. L., Gonzalez J., Minogue T., Sozhamannan S., Gross S. M., Schroth G. P., Kuhn J. H., Donaldson E. F., Delaporte E., Sanchez-Lockhart M., Peeters M., Muyembe-Tamfum J.-J., Alpha Sall A., Palacios G., et Ahuka-Mundeke S.,
2018 Ebola virus disease outbreak in Équateur Province, Democratic Republic of the Congo: a retrospective genomic characterisation,
Lancet Infect Dis, vol. 19, no 6, p. 641‑647, juin 2019. doi: 10.1016/S1473-3099(19)30124-0.

Chotsiri P., Denoeud-Ndam L., Baudin E., Guindo O., Diawara H., Attaher O., Smit M., Guerin P. J., Doumbo O. K., Wiesner L., Barnes K. I., Hoglund R. M., Dicko A., Etard J.-F., et Tarning J.,
Severe Acute Malnutrition Results in Lower Lumefantrine Exposure in Children Treated With Artemether-Lumefantrine for Uncomplicated Malaria,
Clin. Pharmacol. Ther., juin 2019. doi: 10.1002/cpt.1531.

Lenk E. J., Moungui H. C., Boussinesq M., Kamgno J., Nana-Djeunga H. C., Fitzpatrick C., Peultier A.-C. M. M., Klion A. D., Nutman T. B., Fletcher D. A., Pion S. D., Niamsi-Emalio Y., Redekop W. K., Severens J. L., et Stolk W. A.,
A test-and-not-treat strategy for onchocerciasis elimination in Loa loa co-endemic areas: cost analysis of a pilot in the Soa health district, Cameroon,
Clinical Infectious Diseases, juin 2019. doi: 10.1093/cid/ciz461.

Murall C. L., Rahmoun M., Selinger C., Baldellou M., Bernat C., Bonneau M., Boué V., Buisson M., Christophe G., D’Auria G., Taroni F. D., Foulongne V., Froissart R., Graf C., Grasset S., Groc S., Hirtz C., Jaussent A., Lajoie J., Lorcy F., Picot E., Picot M.-C., Ravel J., Reynes J., Rousset T., Seddiki A., Teirlinck M., Tribout V., Tuaillon É., Waterboer T., Jacobs N., Bravo I. G., Segondy M., Boulle N., et Alizon S.,
Natural history, dynamics, and ecology of human papillomaviruses in genital infections of young women: protocol of the PAPCLEAR cohort study,
BMJ Open, vol. 9, no 6, p. e025129, juin 2019. doi: 10.1136/bmjopen-2018-025129.

Viala B., Zaidi F. Z., Bastide M., Dumont Y., Le Moing V., Jean-Pierre H., et Godreuil S.,
Assessment of the In Vitro Activities of Ceftolozane/Tazobactam and Ceftazidime/Avibactam in a Collection of Beta-Lactam-Resistant Enterobacteriaceae and Pseudomonas aeruginosa Clinical Isolates at Montpellier University Hospital, France,
Microb. Drug Resist., juin 2019. doi: 10.1089/mdr.2018.0439.

Dah T. T. E., Couderc C., Coulibaly A., kouamé M. J.-B., Agboyibor M. K., Traoré I., Maradan G., Rojas Castro D., Mensah E., Anoma C., Dembélé Keita B., Spire B., Laurent C., CohMSM Study Group, Couderc C., Granouillac B., Izard S., Laurent C., March L., Peeters M., Serrano L., Berenger C., Bourrelly M., Coulaud P.-J., Maradan G., Mora M., Sagaon-Teyssier L., Spire B., Bernier A., Palvadeau P., Castro D. R., Camara D., Cisse O., Coulibaly A., Keita B. D., Diallo F., Diarra M., Keita A. A., Maiga K., Ouologuem A., Traore F., Thomas Aka N., Anoma C., Babo Yoro S.-A., Coulibaly N. H., Kotchi R., Kouabenan P., Jean-Baptiste kouamé M., Julien Lokrou K., Dibi N’Guessan F., Coulibaly C., Elias Dah T. T., Ilboudo O., Ouedraogo J., Ouedraogo M., Thio E., Toure J. R., Traore A., Traoré I., Yougbare F., Kokouvi K., Agbomadji S., Agboyibor M. K., Attiogbe M., Mawuli Badjassim A., Lorette Ekon A., Kokouba A., Mensah E., Strauss Tablissi D. J., et Dagnra C. A. Y.,
Hepatitis B Virus Prevalence and Vaccination in Men Who Have Sex With Men in West Africa (CohMSM ANRS 12324—Expertise France),
Open Forum Infectious Diseases, vol. 6, no 7, juill. 2019. doi: 10.1093/ofid/ofz249.

Katlama C., Assoumou L., Valantin M.-A., Soulié C., Martinez E., Béniguel L., Bouchaud O., Raffi F., Molina J.-M., Fellahi S., Peytavin G., Marcelin A.-G., Kolta S., Capeau J., Gibowski S., Cardon F., Reynes J., Costagliola D., ANRS 163 ETRAL study, Bernard L., Bottero J., Bouchaud O., Chidiac C., Duvivier C., Goujard C., delMarGutiérrez M., Martinez E., Molina J.-M., Morlat P., Naqvi A., Podzamczer D., Poizot-Martin I., Raffi F., Reynes J., Salmon-Céron D., Simon A., Valantin M.-A., Weiss L., et Yazdanpanah Y.,
Dual therapy combining raltegravir with etravirine maintains a high level of viral suppression over 96 weeks in long-term experienced HIV-infected individuals over 45 years on a PI-based regimen: results from the Phase II ANRS 163 ETRAL study,
Journal of Antimicrobial Chemotherapy, juill. 2019. doi: 10.1093/jac/dkz224.

for the 2-Lady Group, Boyer S., Nishimwe M. L., Sagaon-Teyssier L., March L., Koulla-Shiro S., Bousmah M.-Q., Toby R., Mpoudi-Etame M. P., Ngom Gueye N. F., Sawadogo A., Kouanfack C., Ciaffi L., Spire B., et Delaporte E.,
Cost-Effectiveness of Three Alternative Boosted Protease Inhibitor-Based Second-Line Regimens in HIV-Infected Patients in West and Central Africa,
PharmacoEconomics - Open, juill. 2019. doi: 10.1007/s41669-019-0157-9.

Vinkeles Melchers N. V. S., Coffeng L. E., Boussinesq M., Pedrique B., Pion S. D. S., Tekle A. H., Zouré H. G. M., Wanji S., Remme J. H., et Stolk W. A.,
Projected number of people with onchocerciasis-loiasis co-infection in Africa, 1995 to 2025,
Clinical Infectious Diseases, juill. 2019. doi: 10.1093/cid/ciz647.

Makinson A., Dubois J., Eymard-Duvernay S., Leclercq P., Zaegel-Faucher O., Bernard L., Vassallo M., Barbuat C., Gény C., Thouvenot E., Costagliola D., Ozguler A., Zins M., Simony M., Reynes J., et Berr C.,
Increased Prevalence of Neurocognitive Impairment in Aging People Living With Human Immunodeficiency Virus: The ANRS EP58 HAND 55-70 Study,
Clin. Infect. Dis., juill. 2019. doi: 10.1093/cid/ciz670.

Cogliati M., Desnos-Ollivier M., McCormick-Smith I., Rickerts V., Ferreira-Paim K., Meyer W., Boekhout T., Hagen F., Theelen B., Inácio J., Alonso B., Colom M. F., Trilles L., Montagna M. T., De Donno A., Susever S., Ergin C., Velegraki A., Ellabib M. S., Nardoni S., Macci C., Trovato L., Dipineto L., Akcaglar S., Mlinaric-Missoni E., Bertout S., Vencá A. C. F., Sampaio A. C., Criseo G., Ranque S., Çerikçioğlu N., Marchese A., Vezzulli L., Ilkit M., Pasquale V., Polacheck I., et Lockhart S. R.,
Genotypes and population genetics of cryptococcus neoformans and cryptococcus gattii species complexes in Europe and the mediterranean area,
Fungal Genetics and Biology, vol. 129, p. 16‑29, août 2019. doi: 10.1016/j.fgb.2019.04.001.

Bletsa M., Vidal N., Vrancken B., Lequime S., Peeters M., et Lemey P.,
A4 An amplicon-based approach for universal amplification, sequencing, and assembly of full-length HIV-1 samples from the DRC,
Virus Evolution, vol. 5, no Supplement_1, août 2019. doi: 10.1093/ve/vez002.003.

Coulaud P.-J., Sagaon-Teyssier L., Mimi M., Maradan G., Mora M., Bourrelly M., Dembélé Keita B., Keita A. A., Anoma C., Yoro S.-A. B., Dah E. T. T., Coulibaly C., Mensah E., Agbomadji S., Palvadeau P., Bernier A., Rojas Castro D., Couderc C., Laurent C., Spire B., et CohMSM Study Group,
Changes in risky sexual behaviours among West African MSM enrolled in a quarterly HIV testing and counselling prevention programme (CohMSM ANRS 12324 - Expertise France),
Sex Transm Infect, août 2019. doi: 10.1136/sextrans-2018-053892.

Bertin C., Delorme J., Riquelme M., Peyrière H., Brousse G., Eschalier A., Ardid D., Chenaf C., et Authier N.,
Risk assessment of using off-label morphine sulfate in a population-based retrospective cohort of opioid-dependent patients,
Br J Clin Pharmacol, août 2019. doi: 10.1111/bcp.14082.

Sams K., Desclaux A., et Sow S.,
« They’ll inject you and you’ll die »: from medication non-compliance to acceptance in Guinea’s Ebola treatment units,
Anthropol Med, p. 1‑27, août 2019. doi: 10.1080/13648470.2019.1615749.

The CohMSM Study Group, Coulaud P., Sagaon-Teyssier L., Mimi M., M’madi Mrenda B., Maradan G., Mora M., Bourrelly M., Keita B. D., Keita A. A., Anoma C., Babo Yoro S.-A., Dah T. T. E., Coulibaly C., Mensah E., Agbomadji S., Bernier A., Couderc C., Laurent C., et Spire B.,
Combined Sexual Behavioral Profiles in HIV-Seronegative Men Who have Sex with Men in West Africa (CohMSM ANRS 12324-Expertise France),
Archives of Sexual Behavior, août 2019. doi: 10.1007/s10508-019-01513-z.

The CEREDIH French PID study group, Coignard-Biehler H., Mahlaoui N., Pilmis B., Barlogis V., Brosselin P., De Vergnes N., Debré M., Malphettes M., Frange P., Catherinot E., Pellier I., Durieu I., Perlat A., Royer B., Le Quellec A., Jeziorski E., Fischer A., Lortholary O., Aaron+ L., Adoue D., Aguilar C., Aladjidi N., Alcais A., Amoura Z., Arlet P., Armari-Alla C., Bader-Meunier B., Bayart S., Bertrand Y., Bienvenu B., Blanche S., Bodet D., Bonnotte B., Borie R., Boutard P., Briandet C., Brion J.-P., Brouard J., Cohen-Beaussant S., Costes L., Couderc L.-J., Cougoul P., Courteille V., de Saint Basile G., Devoldere C., Deville A., Donadieu J., Dore E., Dulieu F., Edan C., Entz-Werle N., Fieschi C., Forestier A., Fouyssac F., Gajdos V., Galicier L., Gandemer V., Gardembas M., Gaud C., Guillerm G., Hachulla E., Hamidou M., Hermine O., Hoarau C., Humbert S., Jaccard A., Jacquot S., Jais J.-P., Jaussaud R., Jeandel P.-Y., Kebaili K., Korganow A.-S., Lambotte O., Lanternier F., Larroche C., Lascaux A.-S., Le Moigne E., Le Moing V., Lebranchu Y., Lecuit M., Lefevre G., Lemal R., Te V. L. T., Marie-Cardine A., Silva N. M., Masseau A., Massot C., Mazingue F., Merlin E., Michel G., Millot F., Monlibert B., Monpoux F., Moshous D., Mouthon L., Munzer M., Neven B., Nove-Josserand R., Oksenhendler E., Ouachée-Chardin M., Oudot C., Pagnier A., Pasquali J.-L., Pasquet M., Perel Y., Picard C., Piguet C., Plantaz D., Provot J., Quartier P., Rieux-Laucat F., Roblot P., Roger P.-M., Rohrlich P.-S., Rubie H., Salle V., Sarrot-Reynauld F., Servettaz A., Stephan J.-L., Schleinitz N., Suarez F., Swiader L., Taque S., Thomas C., Tournilhac O., Thumerelle C., Tron F., Vannier J.-P., et Viallard J.-F.,
A 1-Year Prospective French Nationwide Study of Emergency Hospital Admissions in Children and Adults with Primary Immunodeficiency,
Journal of Clinical Immunology, août 2019. doi: 10.1007/s10875-019-00658-9.

Marcy O., Borand L., Ung V., Msellati P., Tejiokem M., Huu K. T., Do Chau V., Ngoc Tran D., Ateba-Ndongo F., Tetang-Ndiang S., Nacro B., Sanogo B., Neou L., Goyet S., Dim B., Pean P., Quillet C., Fournier I., Berteloot L., Carcelain G., Godreuil S., Blanche S., Delacourt C., et ANRS 12229 PAANTHER 01 STUDY GROUP,
A Treatment-Decision Score for HIV-Infected Children With Suspected Tuberculosis,
Pediatrics, vol. 144, no 3, sept. 2019. doi: 10.1542/peds.2018-2065.

Pion S. D., Nana-Djeunga H., Niamsi-Emalio Y., Chesnais C. B., Deléglise H., Mackenzie C., Stolk W., Fletcher D. A., Klion A. D., Nutman T. B., Boussinesq M., et Kamgno J.,
Implications for annual retesting after a test-and-not-treat strategy for onchocerciasis elimination in areas co-endemic with Loa loa infection: an observational cohort study,
The Lancet Infectious Diseases, oct. 2019. doi: 10.1016/S1473-3099(19)30554-7.

Camelique O., Scholtissen S., Dousset J.-P., Bonnet M., Bastard M., et Hewison C.,
Mobile community-based active case-finding for tuberculosis among older populations in rural Cambodia,
Int. J. Tuberc. Lung Dis., vol. 23, no 10, p. 1107‑1114, oct. 2019. doi: 10.5588/ijtld.18.0611.

Ardizzoni E., Orikiriza P., Ssuuna C., Nyehangane D., Gumsboga M., Taremwa I. M., Turyashemererwa E., Mwanga-Amumpaire J., Langendorf C., et Bonnet M.,
Evaluation of OMNIgene Sputum and Ethanol Reagent for Preservation of Sputum Prior to Xpert and Culture Testing in Uganda,
Journal of Clinical Microbiology, vol. 58, no 1, oct. 2019. doi: 10.1128/JCM.00810-19.

Augier C., Beyne E., Villabona-Arenas C. J., Mpoudi Ngole E., Peeters M., et Ayouba A.,
Identification of a Novel Simian Immunodeficiency Virus-Infected African Green Monkey (Chlorocebus tantalus) Confirms that Tantalus Monkeys in Cameroon Are Infected with a Mosaic SIVagm Lineage,
AIDS Res. Hum. Retroviruses, oct. 2019. doi: 10.1089/AID.2019.0216.

Poizot-Martin I., Lions C., Cheret A., Rey D., Duvivier C., Jacomet C., Allavena C., Huleux T., Bani-Sadr F., Obry-Roguet V., et Makinson A.,
Kaposi sarcoma in people living with HIV: incidence and associated factors in the French DAT’AIDS cohort between 2010 and 2015,
AIDS, p. 1, nov. 2019. doi: 10.1097/QAD.0000000000002450.

Buell K. G., Whittaker C., Chesnais C. B., Jewell P. D., Pion S. D. S., Walker M., Basáñez M.-G., et Boussinesq M.,
Atypical Clinical Manifestations of Loiasis and Their Relevance for Endemic Populations,
Open Forum Infectious Diseases, vol. 6, no 11, nov. 2019. doi: 10.1093/ofid/ofz417.

Chihana M. L., Huerga H., Van Cutsem G., Ellman T., Goemaere E., Wanjala S., Masiku C., Szumilin E., Etard J.-F., Maman D., et Davies M.-A.,
Distribution of advanced HIV disease from three high HIV prevalence settings in Sub-Saharan Africa: a secondary analysis data from three population-based cross-sectional surveys in Eshowe (South Africa), Ndhiwa (Kenya) and Chiradzulu (Malawi),
Global Health Action, vol. 12, no 1, p. 1679472-, nov. 2019. doi: 10.1080/16549716.2019.1679472.

Kounta C. H., Sagaon-Teyssier L., Coulaud P.-J., Mora M., Maradan G., Bourrelly M., Keita A. A., Yoro S.-A. B., Anoma C., Coulibaly C., Dah E. T. T., Agbomadji S., Mensah E., Bernier A., Couderc C., Dembélé Keita B., Laurent C., Spire B., et the CohMSM Study Group,
Transactional sex among men who have sex with men participating in the CohMSM prospective cohort study in West Africa,
PLOS ONE, vol. 14, no 11, p. e0217115, nov. 2019. doi: 10.1371/journal.pone.0217115.

Keita A. K., Vidal N., Toure A., Diallo M. S. K., Magassouba N., Baize S., Mateo M., Raoul H., Mely S., Subtil F., Kpamou C., Koivogui L., Traore F., Sow M. S., Ayouba A., Etard J. F., Delaporte E., Peeters M., et POSTEBOGUI Study Group,
A 40 months follow-up of Ebola virus disease survivors in Guinea (Postebogui) reveals longterm detection of Ebola viral RNA in semen and breast milk,
Open Forum Infectious Diseases, nov. 2019. doi: 10.1093/ofid/ofz482.

Kassi F. K., Drakulovski P., Bellet V., Roger F., Chabrol A., Krasteva D., Doumbia A., Landman R., Kakou A., Reynes J., Delaporte E., Menan H. E. I., et Bertout S.,
Cryptococcus genetic diversity and mixed infections in Ivorian HIV patients: A follow up study,
PLOS Neglected Tropical Diseases, vol. 13, no 11, p. e0007812, nov. 2019. doi: 10.1371/journal.pntd.0007812.

Chesnais C. B., Awaca-Uvon N.-P., Vlaminck J., Tambwe J.-P., Weil G. J., Pion S. D., et Boussinesq M.,
Risk factors for lymphatic filariasis in two villages of the Democratic Republic of the Congo,
Parasites & Vectors, vol. 12, no 1, déc. 2019. doi: 10.1186/s13071-019-3428-5.

Cissé A.-M., Laborde-Balen G., Kébé-Fall K., Dramé A., Diop H., Diop K., FatouNiasse-Traoré, Coulibaly M., Have N.-N., Vidal N., Thiam S., Wade A. S., Peeters M., Taverne B., Msellati P., et Touré-Kane C.,
High level of treatment failure and drug resistance to first-line antiretroviral therapies among HIV-infected children receiving decentralized care in Senegal,
BMC Pediatrics, vol. 19, no 1, déc. 2019. doi: 10.1186/s12887-019-1420-z.

Fiorentino M., Sagaon-Teyssier L., Ndiaye K., Suzan-Monti M., Mengue M.-T., Vidal L., Kuaban C., March L., Laurent C., Spire B., Boyer S., et EVOLCam Study Group,
Intimate partner violence against HIV-positive Cameroonian women: Prevalence, associated factors and relationship with antiretroviral therapy discontinuity-results from the ANRS-12288 EVOLCam survey,
Womens Health (Lond), vol. 15, p. 1745506519848546, déc. 2019. doi: 10.1177/1745506519848546.

Gaudard P., Saour M., Morquin D., David H., Eliet J., Villiet M., Daures J.-P., et Colson P.,
Acute kidney injury during daptomycin versus vancomycin treatment in cardiovascular critically ill patients: a propensity score matched analysis,
BMC Infectious Diseases, vol. 19, no 1, déc. 2019. doi: 10.1186/s12879-019-4077-1.

Gomes M. G. M., Oliveira J. F., Bertolde A., Ayabina D., Nguyen T. A., Maciel E. L., Duarte R., Nguyen B. H., Shete P. B., et Lienhardt C.,
Introducing risk inequality metrics in tuberculosis policy development,
Nature Communications, vol. 10, no 1, déc. 2019. doi: 10.1038/s41467-019-10447-y.

Hancart Petitet Pascale,
Lorsque la fille doit disparaître. Rappel théorique et déclinaisons du « savoir d’autorité » en Inde,
Sciences sociales et santé, vol. 37, no 4, p. 31‑5, déc. 2019.

Huerga H., Ferlazzo G., Wanjala S., Bastard M., Bevilacqua P., Ardizzoni E., Sitienei J., et Bonnet M.,
Mortality in the first six months among HIV-positive and HIV-negative patients empirically treated for tuberculosis,
BMC Infectious Diseases, vol. 19, no 1, déc. 2019. doi: 10.1186/s12879-019-3775-z.

Larcher R., Maury C., Charbit J., Jean-Pierre H., Le Moing V., Klouche K., et Capdevila X.,
Cervical anaerobic vertebral osteomyelitis following surgical tracheotomy: a case report,
BMC Infectious Diseases, vol. 19, no 1, déc. 2019. doi: 10.1186/s12879-019-4291-x.

the DAT’AIDS STUDY GROUP, Lions C., Cabras O., Cotte L., Huleux T., Gagneux-Brugnon A., Makinson A., Cabié A., Bonnet B., Duvivier C., Hocqueloux L., Cua E., Cheret A., Hustache-Mathieu L., Obry-Roguet V., Jacomet C., et Poizot-Martin I.,
Missed opportunities of HIV pre-exposure prophylaxis in France: a retrospective analysis in the French DAT’AIDS cohort,
BMC Infectious Diseases, vol. 19, no 1, déc. 2019. doi: 10.1186/s12879-019-3915-5.

Faria N. R., Vidal N., Lourenco J., Raghwani J., Sigaloff K. C. E., Tatem A. J., van de Vijver D. A. M., Pineda-Peña A.-C., Rose R., Wallis C. L., Ahuka-Mundeke S., Muyembe-Tamfum J.-J., Muwonga J., Suchard M. A., Rinke de Wit T. F., Hamers R. L., Ndembi N., Baele G., Peeters M., Pybus O. G., Lemey P., et Dellicour S.,
Distinct rates and patterns of spread of the major HIV-1 subtypes in Central and East Africa,
PLOS Pathogens, vol. 15, no 12, p. e1007976, déc. 2019. doi: 10.1371/journal.ppat.1007976.

Demontès M., Eymard Duvernay S., Allavena C., Jovelin T., Reynes J., Hentzien M., Ravaux I., Delobel P., Bregigeon S., Rey D., Ferry T., Gagneux-Brunon A., Robineau O., Pugliese P., Duvivier C., Cabié A., Chirouze C., Jacomet C., Lamaury I., Merrien D., Hoen B., Hocqueloux L., Cheret A., Katlama C., Arvieux C., Krolak-Salmon P., Makinson A., et For the Dat’AIDS Study Group,
Multimorbidity in Elderly Subjects according to the year of diagnosis of HIV-Infection - A Cross-Sectional DATAIDS Cohort Study,
Clinical Infectious Diseases, déc. 2019. doi: 10.1093/cid/ciz1171.

Salou M., Butel C., Comlan A. S., Konou A. A., Tegueny K., Ehlan A., Lack F., Dossim S., Ayouba A., Delaporte E., Dagnra A. Y., et Peeters M.,
Challenges of scale-up to Dolutegravir based regimens in sub-Saharan Africa: a case study in Togo,
AIDS, déc. 2019. doi: 10.1097/QAD.0000000000002470.

Dufour S., Piroth L., Chirouze C., Tattevin P., Becker A., Braquet P., Ferry T., Duval X., Le Moing V., et VIRSTA/AEPEI Study Group,
Staphylococcus aureus Bloodstream Infection in Patients With Prosthetic Joints in the Prospective VIRSTA Cohort Study: Frequency and Time of Occurrence of Periprosthetic Joint Infection,
Open Forum Infect Dis, vol. 6, no 12, p. ofz515, déc. 2019. doi: 10.1093/ofid/ofz515.